Author

C. M. Brackett

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

B. M. Gillard· 2 shared A. R. McGray· 1 shared B. A. Foster· 1 shared C. A. Chavel· 1 shared E. Karasik· 1 shared J. H. Tong· 1 shared J. L. Bramson· 1 shared K. P. Lee· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. M. Gillard

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Endogenous CD28 drives CAR T cell responses in multiple myeloma

M. M. Lieberman, J. H. Tong, N. U. Odukwe, C. A. Chavel, T. J. Purdon, R. Burchett, B. M. Gillard, C. M. Brackett, A. R. McGray, J. L. Bramson, R. J. Brentjens, K. P. Lee, S. H. Olejniczak

This study shows that endogenous CD28 signaling is essential for CAR T cell efficacy in multiple myeloma, and transient CD28 blockade may reduce toxicities without compromising long-term survival.

bioRxiv · Mar 21, 2024 · PreprintCancer Biology

Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancer

S. D. Shah, B. M. Gillard, M. M. Wrobel, E. Karasik, M. T. Moser, M. Mastri, N. Sule, C. M. Brackett, W. J. HUSS, B. A. Foster

This paper establishes syngeneic bladder cancer tumor lines that mimic human molecular and immunological features of muscle-invasive bladder cancer subtypes and test cisplatin response.

Frontiers in Oncology · Feb 3, 2023Peer-reviewedCancer Biology